Bizarre Patents
Pillow with retractable umbrella
A pillow assembly having a supporting assembly and a retractable umbrella assembly that is easily transportable and allows a user to support his/her head while covering their face from sunlight.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7371889 | Chemical entities with multiple modes of anti-inflammatory action The invention relates to new chemical compounds that inhibit the various enzymes in the arachidonic acid pathway implicated in inflammatory disease conditions. ... | 05/13/2008 |
| 7312031 | Alpha-complementation viral fusion assay The present invention relates to the use of an alpha complementation assay as a quick, effective, and safe method for the detection of cell fusion mediated by viral proteins. Additionally, the method disclosed herein permits the identification of inhibitors of cell ... | 12/25/2007 |
| 7138406 | Modulators of the glucocorticoid receptor The present invention provides compounds of the formula wherein A is of the formula and X, Y, n, R1–R25 are as described in the speci... | 11/21/2006 |
| 6998501 | Nutritional supplement for lowering serum triglyceride and cholesterol levels Triglycerides and cholesterol in the bloodstream are important factors in the development of cardiovascular disease. The present invention discloses a nutritional supplement comprising a sterol and an omega-3 fatty acid, or an ester thereof, for lowering cholesterol... | 02/14/2006 |
| 6908934 | Therapeutic compounds for treating dyslipidemic conditions Compounds of Formula I and the pharmaceutically acceptable salts and esters thereof, wherein Z is selected from the group consisting of: (a) Formula Ia | 06/21/2005 |
| 6746728 | Compound having tetrahydronaphthalene skeleton and liquid crystal composition containing same A tetrahydronaphthalene derivative represented by the general formula (I) and a liquid crystal composition containing the same. A compound represented by the general formula (I) shows superior liquid crystallinity and co... | 06/08/2004 |
| 6686496 | Treatment of myeloma The compounds of the invention which encompasses a class of compounds having the property of anti-carcinogenic activity against human myeloma r comprising 4-oxo-2-butenoic acid compounds and 3-hydrazino-2,4-dioxobutanoic acid compounds and more specifical... | 02/03/2004 |
| 6538149 | ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO [1,2-G]CHROM-3-ENE, BENZO[1,2-G]-THIOCHROM-3-ENE AND BENZO [1,2-G]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY Compounds of the formula ##STR1## where the symbols have the meaning defined in the specification, have retinoid, retinoid antagonist and/or retinoid inverse-agonist-like biological activity.... | 03/25/2003 |
| 6538090 | Organic anti-reflective polymer and method for manufacturing thereof Polymers are disclosed having the following formula 1 or 2: ##STR1## Polymers of the present invention can be used as an ARC material useful for submicrolithography processes using 248 nm KrF, 193 nm ArF and 157 nm F2 lasers. The polymers conta... | 03/25/2003 |
| 6495710 | Synthesis and use of dimethyl 1,5-naphthalenedicarboxlyates and intermediates therefrom The synthesis of dimethyl-1,5-naphthalenedicarboxylate and polymers and articles formed therefrom is disclosed, as well as applications for dimethyl-1,5-naphthalenedicarboxylate, its corresponding acid 1,5-NDA, and various synthesis intermediates.... | 12/17/2002 |
| 6291719 | Methods and equipments of using dual functional catalyst of packing type The present invention relates to a method of catalyzing etherification, esterification, hydration, ether cleavage, isomerization alkylation, or other reactions which are catalyzable with an acid or molecular sieve catalyst. Said reactions are conducted us... | 09/18/2001 |
| 6180815 | Anti-viral compounds The present invention provides compounds which inhibit an envelope virus by inhibiting the fusion of the virus with the host cell. The virus may be inhibited in an infected cell, a cell susceptible of infection or a mammal in need thereof.... | 01/30/2001 |
| 6180816 | Anti-viral compounds The present invention provides compounds which inhibit an envelope virus by inhibiting the fusion of the virus with the host cell. The virus may be inhibited in an infected cell, a cell susceptible of infection or a mammal in need thereof.... | 01/30/2001 |
| 6175034 | Anti-viral compounds The present invention provides compounds which inhibit an envelope virus by inhibiting the fusion of the virus with the host cell. The virus may be inhibited in an infected cell, a cell susceptible of infection or a mammal in need thereof.... | 01/16/2001 |
| 5750678 | Water-soluble dextran fatty acid esters and their use as solubilizers The invention relates to a water-soluble, haemolytically inactive dextran fatty carboxylate with amphiphilic properties made from a dextran with an average molecular weight of 5,000 to 100,000 and a C10 to C14 fatty acid, preferably ... | 05/12/1998 |
| 4997980 | Ethanedioic acid hydrazide compounds suitable for use in high contrast photographic emulsions Disclosed are novel compounds of the formula: ##STR1## wherein: X=--NR5 R6, or --OR7 ; R1 and R2 are independently hydrogen, substituted or unsubstituted alkyl, haloalkyl, hydroxyalkyl alkoxyalkyl, al... | 03/05/1991 |
| 4874890 | Process for the production of deuterated methyl acrylate or deuterated methyl methacrylate There is provided the improved process for the production of deutrated methyl acrylate or methacrylate by the direct substitution of deuterium for hydrogens in methyl acrylate or methacrylate in the presence of a platinum Group metal catalyst.... | 10/17/1989 |
| 4874891 | Open "D" ring hormone analogs Compounds of the formula: ##STR1## and the pharmaceutically acceptable esters thereof, wherein rings A and B are selected from the group consisting of ##STR2## wherein x represents an aromatic ring, or the presence or absence of 0, 1, or ... | 10/17/1989 |
| 4808632 | Fluoranthene derivatives The present invention relates to compounds of formula (I) or a monomethyl or a monoethyl ether thereof (the compound of formula (I) including these ethers may contain no more than 30 carbon atoms in total); ethers, esters thereof; acid addition salts thereof; ... | 02/28/1989 |
| 4808625 | Phenanthrene derivatives The present invention relates to compounds of formula (I) or a monoethyl ether thereof (the compound of formula (I) including these ethers may contain no more than 30 carbon atoms in total); ethers, esters thereof; acid addition salts thereof; wherein Ar is a ... | 02/28/1989 |
| 4803222 | Fluoranthene derivatives The present invention relates to compounds of formula (I) or a monomethyl or a monoethyl ether thereof (the compound of formula (I) including these ethers may contain no more than 30 carbon atoms in total); ethers, esters thereof; acid addition salts thereof; ... | 02/07/1989 |
| 4803221 | Anthracene derivatives The present invention relates to compounds of formula (I) or a monomethyl or a monoethyl ether thereof (the compound of formula (I) including these ethers may contain no more than 30 carbon atoms in total); ethers, esters thereof; acid addition salts thereof; ... | 02/07/1989 |
| 4775496 | Reaction product of a rosin acid and an antidegradant There is disclosed a reaction product of a rosin acid and a polyfunctional compound having at least one functional group capable of reacting with a carboxylic acid functionality and another functional group having antidegradant properties. The reaction pr... | 10/04/1988 |
| 4732897 | Steroidic 5-reductase inhibitors The present invention relates to new 4-aza-17ଲ-substituted 5-androstan-3-ones, to a process for their preparation, to pharmacological compostions containing them, and to the use of said compounds as inhibitors of androgen action by means of t... | 03/22/1988 |
| 4720587 | Fluoranthene derivatives The present invention relates to compounds of formula (I) or a monomethyl or a monoethyl ether thereof (the compound of formula (I) including these ethers may contain no more than 30 carbon atoms in total); ethers, esters thereof; acid addition salts thereof; ... | 01/19/1988 |
| 4719046 | Crysene derivatives The present invention relates to compounds of formula (I) or a monomethyl or a monoethyl ether thereof (the compound of formula (I) including these ethers may contain no more than 30 carbon atoms in total); ethers, esters thereof; acid addition salts thereof; ... | 01/12/1988 |
| 4719049 | Anthracene derivatives The present invention relates to compounds of formula (I) or a monomethyl or a monoethyl ether thereof (the compound of formula (I) including these ethers may contain no more than 30 carbon atoms in total); ethers, esters thereof; acid addition salts thereof; ... | 01/12/1988 |
| 4719055 | Phenanthrene derivatives The present invention relates to compounds of formula (1) or a monomethyl ether thereof (the compound of formula (1) including these ethers may contain no more than 30 carbon atoms in total); ethers, esters thereof; acid addition salts thereof; wherein Ar is a... | 01/12/1988 |
| 4585576 | Liquid-crystal nematic substances What is described is an improved opto-electronic component and display which uses novel liquid crystal nematic substances for the control of the light transmission and for the display of numbers symbols and images. The novel nematic liquid crystal substan... | 04/29/1986 |
| 4421670 | Liquid crystal dihydrophenanthrene substances This invention relates to new liquid crystal dihydrophenanthrene substances for utilization in electro-optical devices for the modulation of light as well as the representation of numerals, signs and images. It has been found that new liquid-crystal 7-n-a... | 12/20/1983 |
| 4147777 | Sericosides and method of use Pharmaceutically active compounds of the formula ##STR1## wherein R1, R2, R3 and R4, which may be the same or different, each represents a hydrogen atom or a substituted or unsubstituted aliphatic or aromat... | 04/03/1979 |
| 4076944 | 3ଲ,14ଲ-Dihydroxy-14,17-seco-D-bisnorandrostan-17-oic acid derivatives 15-Oxasteroids of the androstane, pregnane, estrane, and 19-norpregnane series are useful as hormonal agents.... | 02/28/1978 |
| 4069240 | Nuclear hydrogenation of n-aryl carbamates N-Alicyclic carbamates, useful in making polyurethanes, are prepared by nuclear hydrogenation of an N-aryl carbamate using a group VIII transition metal catalyst. E.g., dimethyl 4,4'-methylenedicarbanilate is contacted with hydrogen and ruthenium catalyst... | 01/17/1978 |
| 4013713 | Diarylvinyl-dihydrophenanthrene compounds New diarylvinyl-dihydrophenanthrene compounds of the formula ##STR1## wherein R1, R1 ', R2, R2 ', R3 and R3 ' are identical or different and represent hydrogen, alkyl with 1 to 12 carbon ... | 03/22/1977 |
| 4009193 | Bisstyrylaryl compounds Bisstyryl-substituted aryl compounds of the formula (I): ##STR1## where X is arylene and R1 and R5 are substituents common to the dye art. The compounds are useful as optical brighteners, particularly for acrylonitrile polymers,... | 02/22/1977 |
| 3992437 | Polyhydrophenanthrene derivatives Alkyl polyhydro-2-phenanthrylideneacetates are prepared by interacting the corresponding 2-oxopolyhydrophenanthrenes with a tri-lower-alkyl -phosphono-lower-alkanoate. Said alkyl polyhydro-2-phenanthrylideneacetates are hydrolyzed to the free acid,... | 11/16/1976 |
| 3987116 | Ethynylaryl compounds and derivatives thereof Novel ethynylaryl compounds and derivatives are described. Their use in the treatment of inflammation is also disclosed.... | 10/19/1976 |
| 3984419 | Perhydrofluorenetetrol and perhydro-phenanthrenetetrol derivatives Compounds are provided having the structure ##SPC1## Wherein n is 1 or 2, n1 is 0, 1 or 2 and n2 is 0, 1, 2 or 3, R1, R2, R3 and R4 may be the same or different and can be hydrogen, lower a... | 10/05/1976 |
| 3933893 | Derivatives of 9-phenanthrene Novel bis basic esters of 9-substituted phenanthrene and related 9-oxa and 9-aza derivatives thereof, their preparation and use for the prevention and inhibition of viral infections are disclosed.... | 01/20/1976 |
| 3932482 | Polyhydro-2-phenanthrylideneacetic acids and esters thereof Alkyl polyhydro-2-phenanthrylideneacetates are prepared by interacting the corresponding 2-oxopolyhydrophenanthrenes with a tri-lower-alkyl -phosphono-lower-alkanoate. Said alkyl polyhydro-2-phenanthrylideneacetates are hydrolyzed to the free acid,... | 01/13/1976 |
